MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities. - Gatesman TA; Varadharajan S; Johnson BJ; Duchatel RJ; Pathak R; Cruz AF; Wolfe HG; Halligan K; Garton LG; Johnson MA; Li F; Chilukuri A; et al. (Cell reports, 2026)